K183019 is an FDA 510(k) clearance for the SIS Software version 3.3.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.
Submitted by Surgical Information Sciences, Inc. (Minneapolis, US). The FDA issued a Cleared decision on March 19, 2019 after a review of 139 days - within the typical 510(k) review window.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Surgical Information Sciences, Inc. devices
NCT02902328
Completed
Observational
Industry-sponsored
Accuracy Evaluation for SIS Software-based Visualization of Anatomical Brain Structures
Accuracy Evaluation for Software-based Visualization of Anatomical Brain Structures Using Surgical Information Sciences Inc. Algorithms
| Condition studied |
Software Evaluation for Visualizing Anatomical Structures That Are Not Typically Identified on Clinical MR Images |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Sponsor |
Surgical Information Sciences Inc.
(industry)
|
Started 2016-03-01
→
Primary completion 2016-09-01
Primary outcome
Validation of the accurate visualization of brain structures based on SIS algorithms
Study completed - no results published.
This trial concluded in 2016 but has not posted
results to ClinicalTrials.gov. Completed studies without public results are common
in industry-sponsored device trials; the data may be referenced in the
510(k) Summary PDF or remain unpublished.
Individual participant data will not be shared.
View full study on ClinicalTrials.gov